NewslettersImmune Regulation NewsBiocytogen Announces RenLite® Licensing Agreement with JanssenBy lbeveridge - March 10, 20230119Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced the signing of a non-exclusive license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Jonson & Johnson.[Biocytogen Pharmaceuticals (Beijing) Co., Ltd]Press Release